Please try another search
BLIRT S.A. engages in the manufacture and sale of recombinant enzymes for the life science industry. It offers proteins and enzymes, such as proteinases, RNase inhibitors, polymerases, nucleases, ligases, and other proteins; and molecular biology reagents, including DNA and RNA extraction, PCR and real-time PCR, reverse transcriptions, and RNA related products. BLIRT S.A. was founded in 1994 and is headquartered in Gdansk, Poland. BLIRT S.A. operates as a subsidiary of Qiagen N.V.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review